GILLIS JONATHAN 4

What Happened
Jonathan Gillis, CAAO and PAO of MapLight Therapeutics (MPLT), sold 3,590 shares in an open-market transaction on April 15, 2026. The weighted-average price was $26.61 per share (range $26.6045–$26.6093), for total proceeds of approximately $95,530. Footnote F1 states the sale represents the shares required to cover statutory tax withholding related to the vesting of restricted stock units (RSUs), so this sale appears routine rather than a discretionary investment decision.

Key Details

• Transaction date: 2026-04-15; Form 4 filed: 2026-04-17 (appears timely).
• Transaction type/code: Sale (S); amount: 3,590 shares.
• Price: Weighted average $26.61; reported per-share range $26.6045–$26.6093 (F2).
• Proceeds: ~ $95,530.
• Purpose: Tax-withholding sale to cover RSU vesting obligations (F1).
• Additional note: F3 indicates 121 shares were acquired under the issuer’s employee stock purchase plan on March 31, 2026.
• Shares owned after the transaction: Not specified in the provided excerpt.

Context
Tax-withholding sales tied to RSU vesting are common and usually considered routine administrative transactions rather than signals about an insider’s view of the company. The filing includes a weighted-average price disclosure and offers to provide per-trade details on request (F2).